Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
Condition(s):LymphomaLast Updated:July 26, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:July 26, 2018Unknown status
Condition(s):Covid19; Myeloma Multiple; Malignant Lymphoma; Hematologic Neoplasms; Stem Cell Transplant ComplicationsLast Updated:February 8, 2022Completed
Condition(s):Peripheral T Cell LymphomaLast Updated:December 4, 2020Recruiting
Condition(s):Recurrent Nasopharynx CarcinomaLast Updated:June 24, 2019Terminated
Condition(s):B-cell LymphomaLast Updated:March 6, 2023Recruiting
Condition(s):REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUSLast Updated:September 13, 2023Withdrawn
Condition(s):Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory T-Cell Non-Hodgkin LymphomaLast Updated:April 3, 2020Terminated
Condition(s):Crohn DiseaseLast Updated:December 22, 2020Terminated
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:July 2, 2009Completed
Condition(s):Diffuse Large B-cell Lymphoma (DLBCL); Relapsed Diffuse Large B-cell Lymphoma (DLBCL); Refractory Diffuse Large B-cell Lymphoma (DLBCL)Last Updated:November 13, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.